25 Feb 2016

Appointment of Non-Executive Director

Abaco Capital (ABA:LON) | 0 0 -2.9% | Mkt Cap: 16.9m

- Singer CM Team
- 3 pages

The appointment of Anand Sharma as a Non-Executive Director strengthens Oxford Pharmascience’s Board at an important time in the group’s development. Oxford Pharmascience is currently undertaking partnering discussions for both OXPzeroTM Ibuprofen and OXPzeroTM Naproxen and we look forward to updates in due course.

Sign up to access

Get access to our full offering from over 30 providers

Appointment of Non-Executive Director

Abaco Capital (ABA:LON) | 0 0 -2.9% | Mkt Cap: 16.9m

Published: 25 Feb 2016
Author: Singer CM Team
Pages: 3

The appointment of Anand Sharma as a Non-Executive Director strengthens Oxford Pharmascience’s Board at an important time in the group’s development. Oxford Pharmascience is currently undertaking partnering discussions for both OXPzeroTM Ibuprofen and OXPzeroTM Naproxen and we look forward to updates in due course.